Eisai and Biogen Launch Weekly Subcutaneous LEQEMBI IQLIK for Early Alzheimer’s in the U.S.

Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in th...

August 26, 2026 | Wednesday | News
Japan Becomes First Market Where Joenja Is Commercially Available for Children Aged 4 to 11

Launch marks first commercial availability of Joenja® (leniolisib) for children aged 4 to 11 worldwide OrphanPacific, Inc. serves as Marketing Au...

August 14, 2026 | Friday | News
Innovent Biologics to Commercialize Daiichi Sankyo’s Vanflyta in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML Innovent Biologics, Inc. (01801.HK) and ...

August 11, 2026 | Tuesday | News
Takeda Receives FDA Approval for ORZEYFUL to Treat Adults with Narcolepsy Type 1

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical T...

August 07, 2026 | Friday | News
CellFiber and Tidewave Bio Collaborate to Advance Manufacturing of Off-the-Shelf Cell Therapy

CellFiber Co., Ltd. (“CellFiber”), a Tokyo-based biotechnology company built on its proprietary CellFiber® cell encapsulation platform, a...

August 07, 2026 | Friday | News
Otsuka Reports Positive Two-Year Phase 3 VISIONARY Results for VOYXACT in IgA Nephropathy

Phase 3 VISIONARY study met its key secondary endpoint, showing an annualized estimated eGFR slope of +0.3 (95% CI, -0.4 to 0.9) mL/min/1.73 m²/...

August 05, 2026 | Wednesday | News
Dasher Neuroscience Completes Phase 2 Enrollment for YA-101 in Multiple System Atrophy Trial

Dasher Neuroscience Holdings Inc. (TPEx: 7829) ("Dasher Neuroscience"), an AI-driven biopharmaceutical company focused on central nervous system (CNS) dr...

July 31, 2026 | Friday | News
Ember LifeSciences and Alfresa Form Strategic Alliance to Strengthen Pharmaceutical Cold Chain in Japan

Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical cold chain solutions, has entered into a capital and business al...

July 31, 2026 | Friday | News
Takeda Reported Phase 3 Zasocitinib Data Showing Strong Skin Clearance in Plaque Psoriasis

Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and pote...

July 30, 2026 | Thursday | News
AGC Biologics Secures Multi-Year Commercial Manufacturing Agreement for Yokohama Facility

Reached a long-term business cooperation with a large pharmaceutical company to help it promote production licensing and commercial supervision and app...

July 30, 2026 | Thursday | News
Anivive Secures Full FDA Approval for AI-Developed Canine Lymphoma Therapy

Anivive converts Laverdia-CA1 to full FDA approval First FDA-approved product to validate Anivive's AI-enabled development model — from drug rep...

June 29, 2026 | Monday | News
Natera’s Signatera Becomes First PMDA-Approved MRD Test in Japan for Colorectal Cancer

  First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commercial launch ex...

June 25, 2026 | Thursday | News
Sanofi Secures Japanese Approval for Wayrilz in Immune Thrombocytopenia

Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) Approval ...

June 24, 2026 | Wednesday | News
Sanofi Wins Japan Approval for Subcutaneous Sarclisa in Multiple Myeloma

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including th...

June 22, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close